Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
8.96
-0.08 (-0.88%)
At close: Mar 6, 2026, 4:00 PM EST
8.92
-0.04 (-0.45%)
After-hours: Mar 6, 2026, 4:04 PM EST
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $237.37 million as of March 6, 2026. Its market cap has increased by 18.64% in one year.
Market Cap
237.37M
Enterprise Value
205.73M
1-Year Change
18.64%
Ranking
Category
Stock Price
$8.96
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $237.37M, an increase of 309.21%. That is a compound annual growth rate of 41.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 237.37M | 22.74% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibikase Therapeutics | 257.15M |
| Surrozen | 252.09M |
| Ovid Therapeutics | 248.65M |
| Orchestra BioMed Holdings | 243.93M |
| Palisade Bio | 242.88M |
| Canton Strategic Holdings | 230.80M |
| Sol-Gel Technologies | 227.45M |
| Achieve Life Sciences | 227.31M |